Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection

Frontiers in Immunology(2021)10.3389/fimmu.2021.608890Source: DataRank Database

Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldTopics (80)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Brenndan L. Crumley ORCID,Glen M. Chew ORCID,Elijah Davis,Roberta Bruhn ORCID,Edward L. Murphy ORCID

Live enrichment

PubMed:33767694 PMC:PMC7985073

National Institute of Neurological Disorders and Stroke

Grant: R01NS097147

National Institutes of Health

Grant: 5R01NS097147-02

Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.608890/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.608890/full

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7985073

repositoryhttps://doaj.org/article/fc7b85aac1ec4ddcac0656dff6dac38c

repositoryhttps://escholarship.org/uc/item/4d30f8kn

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Leukocytes, MononuclearT-Lymphocyte SubsetsHumansHuman T-lymphotropic virus 1HTLV-I InfectionsCytokinesAnti-Retroviral AgentsLymphocyte CountTreatment OutcomeDrug Therapy, CombinationViral LoadImmunophenotypingImmunologic MemoryGene Expression RegulationAdultMiddle AgedDisease ManagementFemaleMaleHost-Pathogen InteractionsBiomarkersClinical Decision-MakingImmune Checkpoint InhibitorsImmune Checkpoint Proteins

Keywords

ImmunotherapyPD-1TIM-3Htlv-1Ham/tspLag-3Immune CheckpointsTigitMaleT-Lymphocyte SubsetsLeukocytes2.1 Biological and endogenous factorsAetiologyImmune Checkpoint InhibitorsHuman T-lymphotropic virus 1Disease ManagementMiddle AgedViral LoadTSPInfectious DiseasesTreatment OutcomeAnti-Retroviral AgentsMedical MicrobiologyCombinationHost-Pathogen InteractionsCytokinesDrug Therapy, CombinationFemaleInfectionAdultMononuclearImmunologyClinical Decision-MakingImmunophenotypingRare DiseasesDrug TherapyClinical ResearchGeneticsHumansLymphocyte CountBiomedical and Clinical SciencesNeurosciencesRC581-607Immune Checkpoint ProteinsHTLV-I InfectionsHAMGood Health and Well BeingGene Expression RegulationBiochemistry and cell biologyLeukocytes, MononuclearImmunologic diseases. AllergyImmunologic MemoryBiomarkers

Sustainable Development Goals

SDG 3: 3. Good health